Search Thermo Fisher Scientific
Invitrogen
{{$productOrderCtrl.translations['antibody.pdp.commerceCard.promotion.promotions']}}
{{$productOrderCtrl.translations['antibody.pdp.commerceCard.promotion.viewpromo']}}
{{$productOrderCtrl.translations['antibody.pdp.commerceCard.promotion.promocode']}}: {{promo.promoCode}} {{promo.promoTitle}} {{promo.promoDescription}}. {{$productOrderCtrl.translations['antibody.pdp.commerceCard.promotion.learnmore']}}
Metapneumovirus Fusion glycoprotein F0 (hMPV F0) is a precursor form of the fusion (F) protein found in Human Metapneumovirus (hMPV) which is an enveloped virus responsible for respiratory tract infections particularly in children elderly and immunocompromised individuals. The F protein plays a critical role in viral entry as it facilitates the merger of the viral envelope with host cell membranes enabling the viral genome to access the host's cellular machinery. Initially synthesized as a precursor F0 polypeptide it undergoes cleavage to form the active F1 and F2 subunits with F1 being responsible for the actual fusion activity. This cleavage and activation of the F protein is essential for the virus's infectivity and pathogenicity. The structure of the F protein characterized by its alpha-helical and coiled-coil domains is a target for neutralizing antibodies and antiviral drugs aiming to block the fusion process thereby preventing infection. Research into the Metapneumovirus Fusion glycoprotein F0 provides insights into vaccine development and therapeutic interventions aimed at mitigating the impact of hMPV infections.
仅用于科研。不用于诊断过程。未经明确授权不得转售。